ORCL is rated as a Buy by means of the Portfolio Grader stock evaluator. The approach to investing incorporated in this analytical tool researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking ORCL has had from Portfolio Grader for the last month.
Metlife Inc's Hold recommendation is the conclusion of a process of analysis that is proprietary and produced outcomes that were below average in 6 areas: an economic sector ranked below average in attractiveness, an industry group rated below average in attractiveness, a ranking in its sector group that is in the middle third, ranking in the company's industry group that is in the middle third-below average, analytical scoring that is near average, and a quantitative risk/reward calculation that is average.